SP-420
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SP-420, covering 2015-09-29 to 2025-09-24. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes [Phase 2]